Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Toloxatone and depression].

R Fernández Labriola1, G Caetano Esquivel, M Alvarez

  • 1Centro de Investigaciones Edmundo Fischer (CIEF), Buenos Aires, Argentina.

Acta Psiquiatrica Y Psicologica De America Latina
|December 1, 1991
PubMed
Summary

Toloxatone, a selective reversible MAO A inhibitor, effectively treated 101 depressed inpatients. Patients with lower noradrenergic activity showed better outcomes, indicating its potential for specific depression types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sperm concentration at freezing affects post-thaw quality and fertility of ram semen.

Theriogenology·2011
Same author

Evaluation of the qualitative and quantitative effectiveness of three media of centrifugation (Maxifreeze, Cushion Fluid Equine, and PureSperm 100) in preparation of fresh or frozen-thawed brown bear spermatozoa.

Theriogenology·2011
Same author

Effect of storage method and extender osmolality in the quality of cryopreserved epididymal ram spermatozoa.

Animal reproduction science·2011
Same author

[Obesity as risk factor for lithiasic recurrence].

Actas urologicas espanolas·2011
Same author

Optimization of glycerol concentration and freezing rate in the cryopreservation of ejaculate from brown bear (Ursus arctos).

Reproduction in domestic animals = Zuchthygiene·2011
Same author

Undiluted or extended storage of ram epididymal spermatozoa as alternatives to refrigerating the whole epididymes.

Animal reproduction science·2011

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Depression is a complex mental health disorder.
  • Selective and reversible monoamine oxidase A (MAO A) inhibitors represent a class of antidepressants.
  • Toloxatone is a novel second-generation MAO A inhibitor.

Purpose of the Study:

  • To evaluate the efficacy and safety of Toloxatone in treating depressed inpatients.
  • To identify patient profiles that may predict a better response to Toloxatone treatment.
  • To explore the relationship between biological markers and treatment outcomes.

Main Methods:

  • A double-blind, placebo-controlled study was conducted over 6 weeks.
  • 101 depressed inpatients meeting specific Hamilton Depression Rating Scale and Endogeneity Test criteria were enrolled.

Related Experiment Videos

  • Patients received a daily dose of 400 mg Toloxatone or a placebo. Biological profiles (Phenyl-ethylamine, Noradrenaline, MHPG) were assessed in a subset of patients.

    • Main Results:

    • Significant treatment modifications were observed in 51 out of 101 patients.
    • Among 59 patients receiving Toloxatone, 37 (62.7%) achieved "excellent" or "good" outcomes.
    • Patients with lower baseline noradrenergic activity demonstrated a more favorable response to Toloxatone.

    Conclusions:

    • Toloxatone is an effective treatment for depression, particularly in patients with anxiety-free or inhibited depressive symptoms.
    • Lower noradrenergic activity may serve as a predictive biomarker for Toloxatone efficacy.
    • Toloxatone offers a promising therapeutic option for specific patient subgroups within the spectrum of depressive disorders.